IL169178A0 - Tiotropium containing hfc solution formulations - Google Patents
Tiotropium containing hfc solution formulationsInfo
- Publication number
- IL169178A0 IL169178A0 IL169178A IL16917805A IL169178A0 IL 169178 A0 IL169178 A0 IL 169178A0 IL 169178 A IL169178 A IL 169178A IL 16917805 A IL16917805 A IL 16917805A IL 169178 A0 IL169178 A0 IL 169178A0
- Authority
- IL
- Israel
- Prior art keywords
- solution formulations
- containing hfc
- hfc solution
- tiotropium containing
- tiotropium
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 title 1
- 229940110309 tiotropium Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02028238 | 2002-12-16 | ||
| PCT/EP2003/013692 WO2004054580A1 (en) | 2002-12-16 | 2003-12-04 | Tiotropium containing hfc solution formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL169178A0 true IL169178A0 (en) | 2007-07-04 |
Family
ID=32524008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL169178A IL169178A0 (en) | 2002-12-16 | 2005-06-15 | Tiotropium containing hfc solution formulations |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1575588A1 (en) |
| JP (1) | JP2006510680A (en) |
| KR (1) | KR20050085650A (en) |
| CN (1) | CN1726038A (en) |
| AU (1) | AU2003303029A1 (en) |
| BR (1) | BR0317340A (en) |
| CA (1) | CA2510043A1 (en) |
| IL (1) | IL169178A0 (en) |
| MX (1) | MXPA05006383A (en) |
| PL (1) | PL375868A1 (en) |
| RU (1) | RU2005122444A (en) |
| WO (1) | WO2004054580A1 (en) |
| ZA (1) | ZA200503546B (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7273603B2 (en) * | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
| NZ563596A (en) * | 2005-05-02 | 2011-01-28 | Boehringer Ingelheim Int | Crystalline form of tiotropium bromide anhydrate |
| EP1879888A2 (en) * | 2005-05-02 | 2008-01-23 | Boehringer Ingelheim International GmbH | Crystalline forms of tiotropium bromide |
| US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| MX2007009988A (en) * | 2005-12-19 | 2008-02-22 | Sicor Inc | Novel forms of tiotropium bromide and processes for preparation thereof. |
| EP2201934A1 (en) | 2008-12-23 | 2010-06-30 | CHIESI FARMACEUTICI S.p.A. | Tiotropium aerosol formulation products with improved chemical stability |
| PE20121467A1 (en) | 2009-12-23 | 2012-11-07 | Chiesi Farma Spa | AEROSOL FORMULATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| PE20121396A1 (en) | 2009-12-23 | 2012-10-24 | Chiesi Farma Spa | PHARMACEUTICAL COMPOSITION INCLUDING GLYCOPYRONIUM BROMIDE AND FORMOTEROL |
| GB201200504D0 (en) * | 2011-12-19 | 2012-02-22 | Teva Branded Pharmaceutical Prod R & D Inc | An inhaler |
| GB201200525D0 (en) * | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| JP6335798B2 (en) | 2012-02-28 | 2018-05-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | New propellant-containing tiotropium formulation |
| CN104918604A (en) * | 2012-10-23 | 2015-09-16 | 西普拉有限公司 | Pharmaceutical composition |
| CA2930173A1 (en) * | 2013-11-22 | 2015-05-28 | Teva Branded Pharmaceutical Products R&D, Inc. | An inhalable medicament |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| WO2018051132A1 (en) * | 2016-09-19 | 2018-03-22 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
| WO2018051128A1 (en) | 2016-09-19 | 2018-03-22 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
| WO2018051133A1 (en) | 2016-09-19 | 2018-03-22 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
| UA123919C2 (en) | 2016-09-19 | 2021-06-23 | Мехікем Флуор С.А. Де С.В. | Pharmaceutical composition |
| GEP20217240B (en) * | 2016-09-19 | 2021-03-25 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG52459A1 (en) * | 1992-12-09 | 1998-09-28 | Boehringer Ingelheim Pharma | Stabilized medicinal aerosol solution formulations |
| DE10056104A1 (en) * | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts |
-
2003
- 2003-12-04 EP EP03813106A patent/EP1575588A1/en not_active Withdrawn
- 2003-12-04 RU RU2005122444/15A patent/RU2005122444A/en not_active Application Discontinuation
- 2003-12-04 MX MXPA05006383A patent/MXPA05006383A/en not_active Application Discontinuation
- 2003-12-04 CN CNA2003801063667A patent/CN1726038A/en active Pending
- 2003-12-04 JP JP2004559752A patent/JP2006510680A/en active Pending
- 2003-12-04 BR BR0317340-2A patent/BR0317340A/en not_active IP Right Cessation
- 2003-12-04 PL PL03375868A patent/PL375868A1/en unknown
- 2003-12-04 WO PCT/EP2003/013692 patent/WO2004054580A1/en not_active Ceased
- 2003-12-04 CA CA002510043A patent/CA2510043A1/en not_active Abandoned
- 2003-12-04 AU AU2003303029A patent/AU2003303029A1/en not_active Abandoned
- 2003-12-04 KR KR1020057010885A patent/KR20050085650A/en not_active Withdrawn
-
2005
- 2005-05-04 ZA ZA200503546A patent/ZA200503546B/en unknown
- 2005-06-15 IL IL169178A patent/IL169178A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2510043A1 (en) | 2004-07-01 |
| RU2005122444A (en) | 2007-01-27 |
| AU2003303029A1 (en) | 2004-07-09 |
| MXPA05006383A (en) | 2005-08-29 |
| ZA200503546B (en) | 2006-10-25 |
| KR20050085650A (en) | 2005-08-29 |
| BR0317340A (en) | 2005-11-08 |
| CN1726038A (en) | 2006-01-25 |
| PL375868A1 (en) | 2005-12-12 |
| WO2004054580A1 (en) | 2004-07-01 |
| JP2006510680A (en) | 2006-03-30 |
| EP1575588A1 (en) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20150039T1 (en) | Pharmaceutical formulations containing methylnaltrexone | |
| IL162642A0 (en) | Formulations | |
| ZA200503546B (en) | Tiotropium containing HFC solution formulations | |
| GB0302671D0 (en) | Pharmaceutical formulations | |
| GB0324886D0 (en) | Medicinal compounds | |
| GB0303396D0 (en) | Medicinal compounds | |
| GB0319874D0 (en) | Novel formulation | |
| EP1694278A4 (en) | Glp-1 pharmaceutical compositions | |
| IL172824A0 (en) | Pharmaceutical formulations | |
| IL171942A0 (en) | Compositions containing ecteinascidin-743 | |
| GB0323701D0 (en) | Formulations | |
| EP1503804A4 (en) | Radiopharmaceutical formulations | |
| GB0302672D0 (en) | Pharmaceutical formulations | |
| ZA200508984B (en) | Antifoaming formulations | |
| GB0325383D0 (en) | Oral formulations | |
| GB0307765D0 (en) | Tissue-adhesive formulations | |
| GB0316341D0 (en) | Pharmaceutical formulations | |
| HRP20040889A2 (en) | Hfa-suspension formulations containing an anticholinergic | |
| IL174589A0 (en) | Pharmaceutical compositions containing tetrahydrobiopterin | |
| AU2003264443A8 (en) | Preparation for external use | |
| GB0214147D0 (en) | Formulations | |
| GB0316335D0 (en) | Pharmaceutical formulations | |
| SI1492513T1 (en) | Hfa-suspension formulations containing an anticholinergic | |
| GB0319551D0 (en) | Formulations | |
| GB0319549D0 (en) | Formulations |